Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts

Journal of Lipid Research

Volumn 56, Issue 1, 2015, Pages 60-69

  Ihlefeld, Katja ^a   Vienken, Hans ^a   Claas, Ralf Frederik ^a   Blankenbach, Kira ^a   Rudowski, Agnes ^a   Ter Braak, Michael ^b   Koch, Alexander ^a   Van Veldhoven, Paul P ^c   Pfeilschifter, Josef ^a   Zu Heringdorf, Dagmar Meyer ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; BREAST CANCER RESISTANCE PROTEIN; CASPASE 3; DOXORUBICIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PROBENECID; SPHINGOSINE 1 PHOSPHATE; SPINSTER 2 PROTEIN; STAUROSPORINE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VERAPAMIL; VERLUKAST; ZOSUQUIDAR; ANILINE DERIVATIVE; FLUO 4; LYASE; SPHINGOSINE 1-PHOSPHATE LYASE (ALDOLASE); XANTHENE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL VACUOLE; CELL VIABILITY; CELLULAR DISTRIBUTION; DRUG DISTRIBUTION; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; WILD TYPE; ANIMAL; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; INTRACELLULAR SPACE; METABOLISM; PROTEIN TRANSPORT;

ALDEHYDE-LYASES; ANILINE COMPOUNDS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; INTRACELLULAR SPACE; MICE; PROTEIN TRANSPORT; UP-REGULATION; XANTHENES;

EID: 84920703644     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M052761     Document Type: Article

References (41)

1. Fodale, V., M. Pierobon, L. Liotta, and E. Petricoin. 2011. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance? Cancer J. 17: 89-95.
2. Young, M. M., M. Kester, and H-G. Wang. 2013. Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J. Lipid Res. 54: 5-19.
3. Truman, J-P., M. García-Barros, L. M. Obeid, and Y. A. Hannun. 2014. Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim. Biophys. Acta. 1841: 1174-1188.
4. Cuvillier, O., G. Pirianov, B. Kleuser, P. G. Vanek, O. A. Coso, S. Gutkind, and S. Spiegel. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine 1-phosphate. Nature. 381: 800-803.
5. Hannun, Y. A., and L. M. Obeid. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9: 139-150.
6. Maceyka, M., K. B. Harikumar, S. Milstien, and S. Spiegel. 2012. Sphingosine 1-phosphate signaling and its role in disease. Trends Cell Biol. 22: 50-60.
7. Blaho, V. A., and T. Hla. 2014. An update on the biology of sphingosine 1-phosphate receptors. J. Lipid Res.
8. Takabe, K., and S. Spiegel. 2014. Export of sphingosine 1-phosphate and cancer progression. J. Lipid Res.
9. Mitra, P., C. A. Oskeritzian, S. G. Payne, M. A. Beaven, S. Milstien, and S. Spiegel. 2006. Role of ABCC1 in export of sphingosine 1-phosphate from mast cells. Proc. Natl. Acad. Sci. USA. 103: 16394-16399.
10. Sato, K., E. Malchinkhuu, Y. Horiuchi, C. Mogi, H. Tomura, M. Tosaka, Y. Yoshimoto, A. Kuwabara, and F. Okajima. 2007. Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J. Neurochem. 103: 2610-2619.
11. Takabe, K., R. H. Kim, J. C. Allegood, P. Mitra, S. Ramachandran, M. Nagahashi, K. B. Harikumar, N. C. Hait, S. Milstien, and S. Spiegel. 2010. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 285: 10477-10486.
12. Lee, Y-M., K. Venkataraman, S-I. Hwang, D. K. Han, and T. Hla. 2007. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat. 84: 154-162.
13. Fukuhara, S., S. Simmons, S. Kawamura, A. Inoue, Y. Orba, T. Tokudome, Y. Sunden, Y. Arai, K. Moriwaki, J. Ishida, et al. 2012. The sphingosine 1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122: 1416-1426.
14. Hisano, Y., N. Kobayashi, A. Yamaguchi, and T. Nishi. 2012. Mouse SPNS2 functions as a sphingosine 1-phosphate transporter in vascular endothelial cells. PLoS ONE. 7: e38941.
15. Yu, M., A. Ocana, and I. F. Tannock. 2013. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Cancer Metastasis Rev. 32: 211-227.
16. Pyne, N. J., and S. Pyne. 2010. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer. 10: 489-503.
17. Schnute, M. E., M. D. McReynolds, T. Kasten, M. Yates, G. Jerome, J. W. Rains, T. Hall, J. Chrencik, M. Kraus, C. N. Cronin, et al. 2012. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem. J. 444: 79-88.
18. Rex, K., S. Jeffries, M. L. Brown, T. Carlson, A. Coxon, F. Fajardo, B. Frank, D. Gustin, A. Kamb, P. D. Kassner, et al. 2013. Sphingosine kinase activity is not required for tumor cell viability. PLoS ONE. 8: e68328.
19. Colié, S., P. P. van Veldhoven, B. Kedjouar, C. Bedia, V. Albinet, S-C. Sorli, V. Garcia, M. Djavaheri-Mergny, C. Bauvy, P. Codogno, et al. 2009. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Cancer Res. 69: 9346-9353.
20. Aguilar, A., and J. D. Saba. 2012. Truth and consequences of sphingosine 1-phosphate lyase. Adv. Biol. Regul. 52: 17-30.
21. Brizuela, L., I. Ader, C. Mazerolles, M. Bocquet, B. Malavaud, and O. Cuvillier. 2012. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. Mol. Cancer Ther. 11: 1841-1851.
22. Reiss, U., B. Oskouian, J. Zhou, V. Gupta, P. Sooriyakumaran, S. Kelly, E. Wang, A. H. Merrill, and J. D. Saba. 2004. Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J. Biol. Chem. 279: 1281-1290.
23. Min, J., P. P. van Veldhoven, L. Zhang, M. H. Hanigan, H. Alexander, and S. Alexander. 2005. Sphingosine 1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol. Cancer Res. 3: 287-296.
24. Oskouian, B., P. Sooriyakumaran, A. D. Borowsky, A. Crans, L. Dillard-Telm, Y. Y. Tam, P. Bandhuvula, and J. D. Saba. 2006. Sphingosine 1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc. Natl. Acad. Sci. USA. 103: 17384-17389.
25. Claas, R. F., M. Ter Braak, B. Hegen, V. Hardel, C. Angioni, H. Schmidt, K. H. Jakobs, P. P. van Veldhoven, and D. Meyer zu Heringdorf. 2010. Enhanced Ca 2+ storage in sphingosine 1-phosphate lyase-deficient fibroblasts. Cell. Signal. 22: 476-483.
26. 2+ homoeostasis in sphingosine 1-phosphate lyasedeficient fibroblasts. Biochem. J. 447: 457-464.
27. Pilorget, A., M. Demeule, S. Barakat, J. Marvaldi, J. Luis, and R. Béliveau. 2007. Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells. J. Neurochem. 100: 1203-1210.
28. Schmidt, H., R. Schmidt, and G. Geisslinger. 2006. LC-MS/MSanalysis of sphingosine 1-phosphate and related compounds in plasma samples. Prostaglandins Other Lipid Mediat. 81: 162-170.
29. Karaca, I., I. Y. Tamboli, K. Glebov, J. Richter, L. H. Fell, M. O. Grimm, V. J. Haupenthal, T. Hartmann, M. H. Gräler, G. van Echten-Deckert, et al. 2014. Deficiency of sphingosine 1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein. J. Biol. Chem. 289: 16761-16772.
30. Loh, K. C., D. Baldwin, and J. D. Saba. 2011. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond. Anticancer. Agents Med. Chem. 11: 782-793.
31. Chipuk, J. E., G. P. McStay, A. Bharti, T. Kuwana, C. J. Clarke, L. J. Siskind, L. M. Obeid, and D. R. Green. 2012. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell. 148: 988-1000.
32. Kumar, A., H-S. Byun, R. Bittman, and J. D. Saba. 2011. The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell. Signal. 23: 1144-1152.
33. Cannon, R. E., J. C. Peart, B. T. Hawkins, C. R. Campos, and D. S. Miller. 2012. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc. Natl. Acad. Sci. USA. 109: 15930-15935.
34. Miller, D. S. 2014. Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule. J. Pharmacol. Exp. Ther. 348: 459-464.
35. Witting, S. R., J. N. Maiorano, and W. S. Davidson. 2003. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J. Biol. Chem. 278: 40121-40127.
36. Hauswald, S., J. Duque-Afonso, M. M. Wagner, F. M. Schertl, M. Lübbert, C. Peschel, U. Keller, and T. Licht. 2009. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clin. Cancer Res. 15: 3705-3715.
37. Hait, N. C., J. Allegood, M. Maceyka, G. M. Strub, K. B. Harikumar, S. K. Singh, C. Luo, R. Marmorstein, T. Kordula, S. Milstien, et al. 2009. Regulation of histone acetylation in the nucleus by sphingosine 1-phosphate. Science. 325: 1254-1257.
38. Fu, D., and I. M. Arias. 2012. Intracellular trafficking of P-glycoprotein. Int. J. Biochem. Cell Biol. 44: 461-464.
39. Di Virgilio, F., T. H. Steinberg, and S. C. Silverstein. 1990. Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium. 11: 57-62.
40. Thomas, D., S. C. Tovey, T. J. Collins, M. D. Bootman, M. J. Berridge, and P. Lipp. 2000. A comparison of fluorescent Ca 2+ indicator properties and their use in measuring elementary and global Ca 2+ signals. Cell Calcium. 28: 213-223.
41. Fletcher, J. I., M. Haber, M. J. Henderson, and M. D. Norris. 2010. ABC transporters in cancer: more than just drug efflux pumps. Nat. Rev. Cancer. 10: 147-156.